RB1 and non-small cell lung carcinoma: EGFR-driven NSCLC cases have been reported with co-mutations including Bcl-2-binding component 3 (TP53), PIK3CA, catenin-ß1 (CTNNB1), and retinoblastoma 1 (RB1) [24].